(IN BRIEF) Sandoz has signed a 10-year virtual PPA with Elawan Energy to develop 150 MW of new solar capacity in Valladolid, Spain, expected to meet almost 90% of electricity demand for its European operations. This partnership is a key … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Financial, Government, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Spain, Switzerland, Technology
Tagged biosimilar medicines, carbon footprint reduction, Castilla y León, clean energy, Climate Action, decarbonization, Elawan Energy, Europe, European operations, generic medicines, Glenn Gerecke, partnership, pharmaceutical industry sustainability, PPA, renewable energy, Sandoz, SBTi, Science Based Targets initiative, solar energy, sustainability, Valladolid, virtual power purchase agreement
New data just released in the two largest global pharma markets show the substantial and growing level of savings made possible by increased use of generic medicines. HOLZKIRCHEN, 21-Jun-2017 — /EuropaWire/ — Generic medicines accounted for 62% of all medicines prescribed … Read the full press release
Posted in Germany, Pharma & Biotech
Tagged Alex Harris, generic medicines, medicines prescribed in Europe, Rabia Khan, Sandoz
Commission fines Lundbeck and other pharma companies for delaying market entry of generic medicines: statement by Vice-President Almunia Joaquín Almunia – Vice President of the European Commission responsible for Competition Policy Press conference, Brussels, 21-6-2013 — /europawire.eu/ — Today the European Commission has found … Read the full press release
Brussels, 20-6-2013 — /europawire.eu/ — The European Commission has imposed a fine of € 93,8 million on Danish pharmaceutical company Lundbeck and fines totalling € 52,2 million on several producers of generic medicines. In 2002, Lundbeck agreed with each of these … Read the full press release
Posted in Belgium, Business, Denmark, European Union, Financial, Government, Healthcare, Law, Pharma & Biotech, Society
Tagged anticompetitive agreements, antidepressant medicine, ANTITRUST, blockbuster antidepressant, citalopram, citalopram molecule, EU antitrust rules, fine, generic medicines, Generics UK, Joaquin Almunia, lump sums, Lundbeck, medicines, Merck KGaA, Patents, pharmaceutical company, Ranbaxy, Zoetis
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?